MultiTERM is a training network providing multidisciplinary training for 13 early stage scientists in 5 host institutes that will deliver a number of excellently trained, highly employable scientists for companies and academia in the field of tissue engineering and regenerative medicine (TERM). The aging population of the EU requires the development of new treatment strategies for diseased, defective, or damaged tissues. Since donor material is often not available, artificial tissue needs to be developed for these purposes. Therefore, smart materials that can be used to replace and repair tissues should be developed. With better tissue engineering possibilities becoming available, improved methods to visualise the fate and effects of these implants are essential and need to be examined. TERM is a multidisciplinary field where scientists need to cut across traditional fields of study. They need to understand completely different aspects - ranging from material choice, cell biology, to clinical translation - to successfully design and clinically implement engineered tissue. Unfortunately, such scientists are scarce, because such TERM-specific interdisciplinary training is missing. To fill the gap that currently exists, the MultiTERM Network will provide early stage researchers with individual and centralized training in key elements of TERM: biomaterials, cell biology, bioreactors, animal modeling, clinical and industrial translation. The MultiTERM Partners, including the industrial partner, are recognized leaders in their fields - ensuring state-of-the-art training - with highly complementary, cross-sectorial skills, and have extensive prior FP experience, assuring achievement of this goal. During their training, the early stage scientists will develop new materials and implants for tissue engineering as well as state-of-the-art novel visualisation procedures to monitor the behaviour of the implanted tissues.